Beta Bionics, Inc. (BBNX) PT Lowered to $30.40 at Ladenburg Thalmann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Price: $16.95 +12.25%
Rating Summary:
11 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 1
Rating Summary:
11 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 1
Join SI Premium – FREE
Ladenburg Thalmann analyst Jeffrey Cohen lowered the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $30.40 (from $32.00) while maintaining a Buy rating.
You May Also Be Interested In
- Beta Bionics Announces Participation at Upcoming Investor Conferences
- Circle Internet Group (CRCL) PT Raised to $46 at Mizuho
- DSM-Firmenich AG (DSFIR:NA) PT Raised to EUR125 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
